Efficacy, safety, and effects on blood pressure of naproxcinod 750 mg twice daily compared with placebo and naproxen 500 mg twice daily in patients with osteoarthritis of the hip: A randomized, double‐blind, parallel‐group, multicenter study

Publisher: John Wiley & Sons Inc

E-ISSN: 1529-0131|62|12|3635-3644

ISSN: 0004-3591

Source: Arthritis & Rheumatism, Vol.62, Iss.12, 2010-12, pp. : 3635-3644

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content